Key Stats for Lumentum Stock
- Past-Week Performance: +16.8%
- 52-Week Range: $45.7 to $783.8
- Current Price: $700.8
What Happened?
Lumentum‘s photonic laser business — which makes the light-emitting chips that power AI data center networks — posted $665.5 million in Q2 FY2026 revenue, up 65% year-over-year, as Nvidia’s $2 billion strategic investment on March 2 confirmed the company’s indium phosphide lasers as irreplaceable infrastructure for the next generation of AI computing, with shares up 51.5% year-to-date entering the S&P 500 on March 23.
Needham raised its price target to $850 from $550 on March 4, citing the Nvidia deal as validation of Lumentum’s leadership in indium phosphide lasers — the specialized compound semiconductor material used to generate the light pulses that carry data between AI chips — alongside a multibillion-dollar purchase commitment and future capacity access rights embedded in the multi-year agreement.
Q3 FY2026 guidance midpoints at $805 million, representing 85%+ year-over-year growth, while the optical circuit switch business — which routes data traffic using light rather than electrical signals, slashing power consumption to less than one-tenth of traditional packet switches — surpassed $400 million in backlog, the majority scheduled for shipment in the second half of calendar 2026, with a new multibillion-dollar multi-year OCS agreement closed March 17.
CFO Wajid Ali stated at the March 18 OFC investor briefing that “we expect that we can grow to $2 billion” in quarterly revenue at 40% non-GAAP operating margins within 18 to 24 months, anchored by the OCS ramp exceeding $1 billion in calendar 2027 and co-packaged optics shipments accelerating through the first half of 2027.
Lumentum’s March 18 acquisition of a former Qorvo fab in Greensboro, North Carolina — its fifth indium phosphide facility, targeting first production in 2028 — extends a capacity roadmap already targeting 50% output growth from Q4 calendar 2025 to Q4 calendar 2026, positioning the company to capture what management estimates as a $90 billion total addressable market within five years as optical connectivity displaces copper inside AI server clusters.
Wall Street’s Take on LITE Stock
Nvidia’s $2 billion investment on March 2 did not merely validate Lumentum’s technology — it locked in the purchase commitments and capacity access rights that convert the OCS backlog, CPO ramp, and 1.6T transceiver acceleration into a multi-year earnings compounding cycle beginning this quarter.
Consensus estimates price that compounding explicitly: revenue is projected to rise 76.7% to $2.91 billion in FY2026, then another 62.2% to $4.71 billion in FY2027, supported by the $400 million-plus OCS backlog shipping in the second half of calendar 2026 and the multi-hundred-million-dollar CPO order delivering in early 2027.
The EPS trajectory is what separates this from a revenue story — normalized EPS is expected to surge from $2.06 in FY2025 to $7.60 in FY2026 and $14.55 in FY2027, a 7x expansion in two years driven by the mix shift toward 200G EML lasers, OCS at semiconductor-like margins, and UHP laser volume scaling in the San Jose fab.
Fourteen of 23 analysts rate LITE a buy, four rate it outperform, and five hold, with a mean price target of $664.22 — modestly below the current $700.81 — reflecting a consensus that has consistently underestimated the OCS ramp and CPO inflection, the same two drivers that pushed Q3 guidance 85% above the prior-year quarter.
The spread between the $455 low target and $900 high target tells the real debate: bears anchor to transceiver margin drag and fab execution risk on the Greensboro acquisition, while bulls price in the multibillion-dollar OCS agreement closed March 17 and the $90 billion five-year TAM management outlined at OFC.
What Does the Valuation Model Say?
The TIKR mid-case model targets $1,627.04 by June 2031, implying a 21.7% annualized return, built on a 43.2% revenue CAGR assumption that is directly supported by the Nvidia purchase commitment, the new OCS LTA, and management’s own 18-to-24-month path to a $2 billion quarterly run rate.
The market is pricing LITE on trailing multiples against a $700 stock, missing that normalized EPS reaches $14.55 by FY2027 — meaning the stock trades at roughly 48x two-year-forward earnings on a business guiding to 40% operating margins.
The OCS multibillion-dollar agreement closed March 17 with an existing hyperscaler customer gives the $2 billion quarterly revenue target concrete backlog support, not just management aspiration, justifying the TIKR model’s $1,627.04 price target.
Management’s confirmation at the March 18 OFC briefing that the company remains sold out through calendar 2027 — even after the 50% capacity increase planned for this calendar year — signals supply constraint, not demand uncertainty, as the primary variable.
If indium phosphide substrate supply tightens beyond the 7-year agreement already in place, or fab yield ramps at Caswell and Greensboro disappoint, the $14.55 FY2027 EPS estimate collapses, removing the primary justification for the current multiple.
Watch the Q3 FY2026 earnings call for the first reported OCS revenue above $100 million in a single quarter and any update to the UHP shipment timeline — those two numbers confirm whether the $2 billion quarterly run rate lands in 9 months or 12.
Should You Invest in Lumentum Holdings Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up LITE stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Lumentum Holdings Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze LITE stock on TIKR for Free →
